{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Embedded derivatives, Compounding effect, Structured product features",
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged ETP that seeks to provide three times the daily performance of the iShares MSCI China ETF, indicating significant leverage and use of derivatives. It uses synthetic replication via derivatives (swaps or similar instruments) to achieve its investment objective, which introduces counterparty and collateral risks that are difficult for retail investors to understand. The product documentation explicitly states the presence of a compounding effect due to daily leverage rebalancing, which can cause returns to deviate significantly from the underlying index over periods longer than one day. The product is classified as a Collateralised Exchange Traded Security (ETP), not a UCITS ETF, and is intended for sophisticated investors with a very short holding period (recommended 1 day), reflecting its complexity and risk. The product carries a highest risk class (7/7) and lacks capital protection. The use of leverage beyond UCITS limits, synthetic replication, embedded derivatives, and complex payoff structures all contribute to its classification as complex under MiFID II Article 25(4)(a)(vi) and Article 57 criteria. According to ESMA and CESR guidance, such leveraged synthetic products with embedded derivatives and complex risk profiles are complex financial instruments requiring an appropriateness assessment before sale to retail clients."
}